The Traumatic Brain Injury Coma-Inducing Drugs market was valued at USD 67.29 Million in 2024 and is expected to reach USD 101.26 Million by 2032, growing at a CAGR of 5.24% (2025-2032). Get insights on trends, segmentation, and key players with Data Bridge Market Research Reports.